Liposomal Delivery: Maximizing Bioavailability A major challenge with oral supplementation is bioavailabilityhow much of the active ingredient is absorbed by the body
Clinical Considerations Disease-associated maternal and/or embryofetal risk Poorly controlled diabetes in pregnancy increases the maternal risk for diabetic ketoacidosis, preeclampsia, spontaneous abortions, preterm delivery, and delivery complications
EMA and the EU regulatory network have been closely monitoring the situation and taking actions since 2022 (see More about the management of these shortages)
10.1016/S2215-0366(22)00260-7 15
Adv Drug Deliv Rev 60:14631470 Sancheti H, Akopian G, Yin F, Brinton RD, Walsh JP, Cadenas E (2013) Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimers disease
Drug Enforcement Administration, Stimulants. M